• Sectors we work in banner(2)

    Quick Reads

Listing Rules changes are in...exciting times for founders and fast-growing companies

min read

The key rule changes, which came into force on 3 December 2021, are a welcome shot in the arm. They should boost the attractiveness of the premium segment of the UK's main market - which plays host to the UK's leading public companies including those in the FTSE 100 and FTSE 250 - for IPOs. 

Targeted and time-limited dual class structures are in, which will enable founders to keep more control and facilitate such companies coming to market sooner, to access the deep pool of capital available via the London markets. Similarly, the free float requirement - the percentage of shares in public hands - is reduced from 25% to 10%. As a counterbalance, the minimum market capitalization threshold has been increased, not to £50 million as initially proposed during consultation, but to a more sensible £30 million given the commercial objective of attracting fast-growing technology and life sciences companies.

All good news, but we now await HM Treasury's review of the prospectus regime which is in equal need of overhaul to, amongst other things, streamline the documentary and approval processes for both primary and secondary fundraisings. Let's hope HM Treasury grasp the nettle. 

Founders who chose to list on the premium section of the market will be allowed to hold shares with enhanced voting rights and make just 10 per cent of shares available to the public, down from 25 per cent.

Our thinking

  • Charles Russell Speechlys advises Ulisses on €1 million seed round fundraising

    Annapaola Negri-Clementi

    News

    min read
  • Charles Russell Speechlys advises the shareholders of Pooky Lighting on its acquisition by leading US lighting company Visual Comfort & Co.

    David Coates

    News

    min read
  • Charles Russell Speechlys advises long standing client SPS on its acquisition of Cleardata

    Hamish Perry

    News

    min read
  • Charles Russell Speechlys awarded “Legal Advisers of the Year” at the HealthInvestor Awards 2026

    David Coates

    News

    min read
  • A founder's guide to SAFEs: fast-tracking investment for UK technology start-ups

    Grace Hudson

    Insights

    min read
  • Case No. 9. Can an arbitration clause be extended to a non-signatory party, and what are the relevant factors?

    Annapaola Negri-Clementi

    Insights

    min read
  • Top 5 things to consider when selling your Financial Services business

    Charlie Ring

    Insights

    min read
  • Ownership, Value and the Next Phase of African Investment

    Greg Stonefield

    Quick Reads

    min read
  • Investing in the UK Living Sector? Here’s what the latest regulatory changes mean

    Sarah Wigington

    Insights

    min read
  • Critical Minerals, Value Capture and the Next Phase of African Dealmaking

    Greg Stonefield

    Quick Reads

    min read
  • Africa M&A Is Recovering — But Execution Matters More Than Optimism

    Greg Stonefield

    Quick Reads

    min read
  • Charles Russell Speechlys appoints corporate and private equity specialist in London

    David Collins

    News

    min read
  • Erell Bauduin and Julia Landru publish in STEP Journal on family business succession planning in France

    Erell Bauduin

    In the Press

    min read
  • Charles Russell Speechlys advises RYDGE Conseil on its acquisition of Fiduciaire Cabexco and Cabexco Proactive

    Yacine Diallo

    News

    min read
  • Retail Collection: Business and Social Enterprise

    Iwan Thomas

    Podcasts

  • When Strategic Relevance Starts to Reshape Capital Markets

    Greg Stonefield

    Quick Reads

    min read
  • Charles Russell Speechlys has advised the founders of legal technology business, Obviously, on its sale to AIM listed RWS, a global AI solutions company

    Mark Howard

    News

    min read
  • Paula Boast MBE comments on the UK-GCC free trade agreement in Gulf Daily News

    Paula Boast MBE

    In the Press

    min read
  • Functional Food and Drink in 2025: Why Gut Health and Cognitive Performance are Driving UK M&A

    Imogen Brown

    Insights

    min read
  • Charles Russell Speechlys moves offices in Milan following consistent growth of Italian practice

    Michael Lingens

    News

    min read
Back to top